A novel class of mono- and di-meric chromium(II) amides has been prepared and characterized. Reaction of [CrCl2(thf)2](thf = tetrahydrofuran) with 2 equivalents of M(NR2)(R = C6H11, Pri, Ph, or phenothiazinyl; M = Li or Na) allowed the formation of the homoleptic amides [{Cr(µ-NR2)(NR2)}2](R = Ph 1a, C6H111b or Pri1c). The reaction is followed by co-ordination of a Lewis base which, although preserving the Cr2(NR2)2 core, remarkably elongated the Cr ⋯ Cr distance forming [{Cr(µ-NR2)(NR2)L}2](R = Ph, L = thf 2). Facile cleavage to give the square-planar monomeric species [Cr(NR2)L2](R = Ph, L = pyridine 3a, thf 3b; NR2= phenothiazinyl, L = thf 3c) occurred upon treatment with an excess of co-ordinating solvent. Reaction with an excess of M(NR2) led to the formation of anionic chromium(II) square-planar metalates [M2Cr(NR2)4L2](R = Ph, M = Na, L = thf 4a; R = Et, M = Li, L = thf 4b or pyridine 4c). A dimeric species with a very short Cr ⋯ Cr contact [{Cr[N(C5H4N-2)2]2}2]·2dmf (dmf = dimethylformamide)5b has been obtained involving a unique three-centre chelating geometry of the bridging amide ligand. The crystal structures of compounds 1b, 2, 3a, 3c, 4c and 5b have been determined.
No takes yet. Share an insight, caveat, or question.
Edema et al. (1993) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: